Photo: Alexander Koryakov / Kommersant
Federal scientific center for research and development of immunological products to them. M. P. Chumakov, Russian Academy of Sciences has completed preclinical testing of a vaccine against coronavirus. Its clinical trials will begin in August 2020. It is reported TASS with reference to the General Director of the center Aidar Ishmukhametova.
The vaccine developed technology, which is close to the Russian produced the first inactivated polio vaccine. It has established itself as the most efficient and safe method to prevent viral infections.
“The trial was attended not only small rodents but also primates, whose reaction to the vaccine is maximally close to human,” said Ishmukhametov. Since the vaccine has successfully passed these tests, further test it on more than 100 volunteers.
Previously, the center “Vector” has announced the start of clinical vaccine trials from COVID-19 on volunteers. According to the head of the Ministry of health of Michael Murashko, the first vaccine plan to register in August 2020.
Video, photo All from Russia.